Calcium Folinate Pentahydrate

• Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer a… Pending
  2024-517269-18-00 Phase III 1 country AIO-Studien gGmbH; National Cancer Institute
• A randomized phase III trial of short-course versus long-course pre-operative chemotherapy with mFOLFIRINOX or PAXG regimen for stage I-III … Pending
  2024-519031-42-00 Phase III 1 country Associazione Italiana Per Lo Studio Del Pancreas
• COLLISION RELAPSE trial Recurrent colorectal liver metastases: repeat local treatment +/- neoadjuvant systemic therapy, a phase III prospect… Recruiting
  2024-515341-41-01 Phase III/IV 1 country Stichting Amsterdam UMC
• FUTURE Recruiting
  2024-517573-24-00 Phase II 1 country Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
• Post-resection/ ablation chemotherapy in patients with metastatic colorectal cancer (FIRE-9 - PORT / AIO-KRK-0418). Prospective, randomized,… Recruiting
  2024-512174-10-00 Phase III 1 country Charite Universitaetsmedizin Berlin KöR
• FOLFOX before surgey compared to risk-adapted chemotherapy after surgery in patients with locally advanced rectal cancer and low risk for lo… Recruiting
  2024-518077-34-00 Phase III 1 country Heidelberg University
• The PRESTO Trial - Organ preservation with durvalumab-based immunotherapy in combination with chemoradiation as definitive therapy for early… Ended
  2024-512980-29-00 Phase II 1 country Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
• Short course radiotherapy versus chemoradiotherapy, followed by consolidation chemotherapy, and selective organ preservation for MRI-defined… Ended
  2024-511577-29-01 Phase III 1 country Goethe University Frankfurt
• DANTE / FLOT8 A randomized, open-label Phase II/III efficacy and safety study of atezolizumab in combination with FLOT versus FLOT alone in … Ended
  2024-514945-12-00 Phase II/III 1 country Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
• NEOadjuvant chemotherapy only compared with standard treatment for Locally Advanced Rectal cancer: a randomized phase II trial Ended
  2024-517748-76-00 Phase I/II 1 country Region Sjaelland
• NeoART – A phase Ib/II platform trial evaluating the safety and activity of neoadjuvant trastuzumab-deruxtecan containing combination therap… Halted
  2024-518841-12-00 Phase I/II 2 countries Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
• Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Ga… Ended
  2023-504834-23-00 Phase III/IV 7 countries Merck Sharp & Dohme LLC
• Organ preservation in locally advanced rectal cancer by radiochemotherapy followed by consolidation chemotherapy. A prospective phase II pil… Ended
  2024-517928-19-00 Phase II 1 country Universitaetsklinikum Tuebingen AöR
• Ramucirumab plus Irinotecan / Leucovorin / 5-FU versus Ramucirumab plus Paclitaxel in patients with advanced or metastatic adenocarcinoma of… Ended
  2024-512934-14-00 Phase III 3 countries Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH

Showing 1–14 of 14 trials